Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Number of holders
-
118
-
Total 13F shares, excl. options
-
16,117,483
-
Shares change
-
+3,764,217
-
Total reported value, excl. options
-
$1,905,155,132
-
Value change
-
+$447,574,728
-
Put/Call ratio
-
72%
-
Number of buys
-
82
-
Number of sells
-
38
-
Price
-
$118.23
Institutional Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q1 2015
As of 31 Mar 2015 FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) had 118 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 16,117,483 shares of stock of the company.
Largest 10 holders included FIRST TRUST ADVISORS LP, MORGAN STANLEY, WELLS FARGO & COMPANY/MN, UBS Group AG, BANK OF AMERICA CORP /DE/, GOLDMAN SACHS GROUP INC, RAYMOND JAMES & ASSOCIATES, LPL Financial LLC, ROYAL BANK OF CANADA, and Ameriprise Financial Inc.
This table shows 118 institutional shareholders of the security as of 31 Mar 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.